MacroGenics Quarterly Income Statements Chart
Quarterly
|
Annual
MacroGenics Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenues: | |||||||||||||||||||||||||||||||||||||||||||||||
| collaborative and other agreements | 6,869,000 | 7,042,000 | 13,676,000 | 101,408,000 | 2,065,000 | 1,449,000 | 5,397,000 | 885,000 | 6,021,000 | 16,686,000 | 59,673,000 | 35,674,000 | 16,863,000 | ||||||||||||||||||||||||||||||||||
| product sales | 2,156,000 | 4,161,000 | 5,248,000 | 4,861,000 | 4,692,000 | 4,695,000 | 5,062,000 | 3,490,000 | 4,104,000 | 4,371,000 | 4,672,000 | ||||||||||||||||||||||||||||||||||||
| contract manufacturing | 15,372,000 | 6,150,000 | 3,315,000 | 4,573,000 | 2,893,000 | 2,276,000 | 169,000 | 4,462,000 | 1,587,000 | 3,615,000 | 8,854,000 | 1,142,000 | 3,992,000 | ||||||||||||||||||||||||||||||||||
| government agreements | 206,000 | 566,000 | 493,000 | 358,000 | 462,000 | 345,000 | 466,000 | 283,000 | 468,000 | 547,000 | 480,000 | ||||||||||||||||||||||||||||||||||||
| total revenues | 22,241,000 | 13,192,000 | 19,353,000 | 110,708,000 | 10,797,000 | 9,104,000 | 10,720,000 | 10,397,000 | 13,136,000 | 24,496,000 | 73,099,000 | 41,734,000 | 26,007,000 | 11,101,000 | 14,147,000 | 15,662,000 | 30,757,000 | 16,881,000 | 52,691,000 | 18,253,000 | 20,257,000 | 13,682,000 | 25,192,000 | 18,741,000 | 10,593,000 | 9,662,000 | 15,794,000 | 20,798,000 | 18,834,000 | 4,695,000 | 152,359,000 | 1,663,000 | 1,666,000 | 2,055,000 | 80,673,000 | 2,846,000 | 8,178,000 | 14,681,000 | 6,716,000 | 71,279,000 | 5,476,000 | 18,382,000 | 9,220,000 | 14,718,597 | 14,906,436 | 20,232,068 | |
| costs and expenses: | |||||||||||||||||||||||||||||||||||||||||||||||
| cost of product sales | 233,000 | 168,000 | 176,000 | 270,000 | 163,000 | 85,000 | 258,000 | 113,000 | 116,000 | 3,007,000 | 180,000 | 48,000 | 947,000 | 1,665,000 | 22,000 | 17,000 | |||||||||||||||||||||||||||||||
| cost of manufacturing services | 8,906,000 | 5,400,000 | 5,257,000 | 1,702,000 | 2,647,000 | 1,846,000 | 3,274,000 | 919,000 | 3,410,000 | 1,675,000 | 136,000 | 2,222,000 | |||||||||||||||||||||||||||||||||||
| research and development | 40,791,000 | 39,698,000 | 38,890,000 | 40,543,000 | 51,732,000 | 46,029,000 | 47,351,000 | 30,131,000 | 43,229,000 | 45,872,000 | 45,653,000 | 48,191,000 | 51,744,000 | 61,438,000 | 55,853,000 | 49,823,000 | 55,780,000 | 53,121,000 | 42,300,000 | 44,656,000 | 57,351,000 | 48,894,000 | 51,957,000 | 44,852,000 | 51,440,000 | 47,060,000 | 46,925,000 | 46,218,000 | 52,014,000 | 45,670,000 | 38,986,000 | 40,984,000 | 34,461,000 | 32,801,000 | 33,340,000 | 27,346,000 | 30,044,000 | 24,103,000 | 22,660,000 | 21,464,000 | 19,650,000 | 18,632,000 | 17,335,000 | 14,568,754 | 14,348,102 | 11,087,919 | |
| selling, general and administrative | 9,302,000 | 10,718,000 | 27,810,000 | 14,104,000 | 14,423,000 | 14,709,000 | 12,560,000 | 12,409,000 | 13,692,000 | 13,527,000 | 13,672,000 | 15,355,000 | 13,669,000 | 16,253,000 | 15,583,000 | 17,161,000 | 15,234,000 | 15,036,000 | |||||||||||||||||||||||||||||
| total costs and expenses | 58,999,000 | 55,816,000 | 72,190,000 | 56,517,000 | 68,978,000 | 62,854,000 | 60,074,000 | 45,899,000 | 58,098,000 | 62,922,000 | 61,116,000 | 66,689,000 | 67,815,000 | 77,739,000 | 72,383,000 | 68,649,000 | 71,036,000 | 68,174,000 | 54,861,000 | 54,388,000 | 67,567,000 | 59,127,000 | 63,847,000 | 56,685,000 | 63,562,000 | 57,279,000 | 57,472,000 | 55,802,000 | 63,148,000 | 54,905,000 | 47,390,000 | 49,387,000 | 42,845,000 | 40,263,000 | 40,579,000 | 33,479,000 | 36,759,000 | 30,124,000 | 28,006,000 | 26,147,000 | 24,495,000 | 22,310,000 | 21,480,000 | 17,827,341 | 18,111,887 | 13,074,474 | |
| income from operations | -36,758,000 | -42,624,000 | -52,837,000 | 54,191,000 | -58,181,000 | -53,750,000 | -49,354,000 | -35,502,000 | -44,962,000 | -38,426,000 | 11,983,000 | -24,955,000 | -41,808,000 | -66,638,000 | -58,236,000 | -52,987,000 | -40,279,000 | -51,293,000 | -2,170,000 | -36,135,000 | -47,310,000 | -45,445,000 | -38,655,000 | -37,944,000 | -52,969,000 | -47,617,000 | -41,678,000 | -35,004,000 | -44,314,000 | -50,210,000 | 104,969,000 | -47,724,000 | -41,179,000 | -38,208,000 | 40,094,000 | -30,633,000 | -28,581,000 | -15,443,000 | -21,290,000 | 45,132,000 | -19,019,000 | -3,928,000 | -12,260,000 | -3,108,744 | -3,205,451 | 7,157,594 | |
| yoy | -36.82% | -20.70% | 7.06% | -252.64% | 29.40% | 39.88% | -511.87% | 42.26% | 7.54% | -42.34% | -120.58% | -52.90% | 3.80% | 29.92% | 2583.69% | 46.64% | -14.86% | 12.87% | -94.39% | -4.77% | -10.68% | -4.56% | -7.25% | 8.40% | 19.53% | -5.16% | -139.71% | -26.65% | 7.61% | 31.41% | -219.03% | 34.43% | 33.68% | -288.32% | -167.87% | 50.28% | 293.15% | 73.65% | -1551.78% | 493.33% | -154.88% | ||||||
| qoq | -13.76% | -19.33% | -197.50% | -193.14% | 8.24% | 8.91% | 39.02% | -21.04% | 17.01% | -420.67% | -148.02% | -40.31% | -37.26% | 14.43% | 9.91% | 31.55% | -21.47% | 2263.73% | -93.99% | -23.62% | 4.10% | 17.57% | 1.87% | -28.37% | 11.24% | 14.25% | 19.07% | -21.01% | -11.74% | -147.83% | -319.95% | 15.89% | 7.78% | -230.88% | 7.18% | 85.07% | -27.46% | -147.17% | -337.30% | 384.19% | -67.96% | 294.37% | -3.02% | -144.78% | |||
| operating margin % | |||||||||||||||||||||||||||||||||||||||||||||||
| interest and other income | 1,414,000 | 1,679,000 | 2,086,000 | 2,118,000 | 2,523,000 | 2,693,000 | 3,282,000 | 3,056,000 | 2,275,000 | 1,073,000 | |||||||||||||||||||||||||||||||||||||
| income before income taxes | -36,146,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| income tax provision | 105,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| net income | -36,251,000 | -41,036,000 | -15,421,000 | 56,309,000 | -55,664,000 | -52,190,000 | -46,072,000 | 17,554,000 | 57,469,000 | -38,009,000 | 12,802,000 | -24,813,000 | -41,304,000 | -66,443,000 | -58,022,000 | -52,886,000 | -39,935,000 | -51,272,000 | -2,087,000 | -36,043,000 | -46,885,000 | -44,724,000 | -30,396,000 | -44,631,000 | -31,767,000 | -45,017,000 | -44,644,000 | -34,029,000 | -43,244,000 | -49,536,000 | 105,727,000 | -47,043,000 | -40,654,000 | -37,655,000 | 40,464,000 | -30,363,000 | |||||||||||
| yoy | -34.88% | -21.37% | -66.53% | 220.78% | -196.86% | 37.31% | -459.88% | -170.75% | -239.14% | -42.79% | -122.06% | -53.08% | 3.43% | 29.59% | 2680.16% | 46.73% | -14.82% | 14.64% | -93.13% | -19.24% | 47.59% | -0.65% | -31.91% | 31.16% | -26.54% | -9.12% | -142.23% | -27.66% | 6.37% | 31.55% | -216.26% | 33.89% | |||||||||||||||
| qoq | -11.66% | 166.10% | -127.39% | -201.16% | 6.66% | 13.28% | -362.46% | -69.45% | -251.20% | -396.90% | -151.59% | -39.93% | -37.84% | 14.51% | 9.71% | 32.43% | -22.11% | 2356.73% | -94.21% | -23.12% | 4.83% | 47.14% | -31.89% | 40.49% | -29.43% | 0.84% | 31.19% | -21.31% | -12.70% | -146.85% | -324.75% | 15.72% | 7.96% | -233.27% | |||||||||||||
| net income margin % | |||||||||||||||||||||||||||||||||||||||||||||||
| other comprehensive loss: | |||||||||||||||||||||||||||||||||||||||||||||||
| unrealized gain on investments | -6,000 | -10,000 | 38,000 | 11,000 | -29,000 | 29,000 | 38,000 | 13,000 | 108,000 | 213,000 | -43,000 | -222,000 | -58,000 | -4,000 | -10,000 | 18,000 | -9,000 | -15,000 | -55,000 | 56,000 | -7,000 | -11,000 | 34,000 | 3,000 | -3,000 | -18,000 | 40,000 | 39,000 | 13,750 | 56,000 | 25,000 | -26,000 | 7,000 | 57,000 | |||||||||||||
| comprehensive loss | -36,257,000 | -41,041,000 | -52,219,000 | -37,996,000 | 12,910,000 | -24,600,000 | -41,347,000 | -58,080,000 | -52,890,000 | -39,945,000 | -51,254,000 | -2,096,000 | -36,058,000 | -46,940,000 | -44,668,000 | -30,403,000 | -44,642,000 | -31,733,000 | -45,014,000 | -44,647,000 | -34,047,000 | -43,204,000 | -49,497,000 | 105,651,000 | -46,987,000 | -37,681,000 | |||||||||||||||||||||
| basic and diluted net income per common share | -570 | -650 | -840 | -610 | 210 | -400 | -670 | -1,080 | -950 | -860 | -660 | -900 | 20 | -660 | -940 | -910 | -620 | -910 | -650 | -990 | -1,060 | -810 | -1,030 | -1,340 | 2,960 | -1,280 | -1,080 | -440 | -0.12 | ||||||||||||||||||
| basic and diluted weighted-average common shares outstanding | 63,136,057,000 | 62,965,415,000 | 62,621,185,000 | 62,290,538,000 | 61,929,198,000 | 61,809,817,000 | 61,433,124,000 | 61,459,831,000 | 61,384,943,000 | 61,324,163,000 | 59,944,717,000 | 61,169,754,000 | 60,068,315,000 | 57,202,846,000 | 54,463,412,000 | 50,018,462,000 | 49,012,663,000 | 48,902,766,000 | 48,845,234,000 | 45,606,651,000 | 42,239,327,000 | 42,153,813,000 | 36,936,560,000 | 36,779,305,000 | 34,958,228,000 | ||||||||||||||||||||||
| unrealized loss on investments | -5,000 | -80,000 | |||||||||||||||||||||||||||||||||||||||||||||
| gain on royalty monetization arrangement | 50,000,000 | 100,930,000 | |||||||||||||||||||||||||||||||||||||||||||||
| other comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||
| comprehensive income | -12,881,250 | 56,347,000 | -55,653,000 | 9,246,000 | 17,592,000 | 57,389,000 | -66,665,000 | -40,629,000 | 40,471,000 | -30,306,000 | |||||||||||||||||||||||||||||||||||||
| net income per common share: | |||||||||||||||||||||||||||||||||||||||||||||||
| basic | -205 | 900 | -890 | 150 | 280 | 930 | |||||||||||||||||||||||||||||||||||||||||
| diluted | -205 | 900 | -890 | 150 | 280 | 920 | |||||||||||||||||||||||||||||||||||||||||
| weighted-average common shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||||
| basic | 62,744,005,000 | 62,663,677,000 | 61,980,680,000 | 61,880,096,000 | |||||||||||||||||||||||||||||||||||||||||||
| diluted | 62,865,841,000 | 62,663,677,000 | 62,244,602,000 | 62,261,646,000 | |||||||||||||||||||||||||||||||||||||||||||
| royalty revenue | 98,000 | 160,000 | 10,000 | 422,000 | |||||||||||||||||||||||||||||||||||||||||||
| interest expense | -774,000 | -656,000 | |||||||||||||||||||||||||||||||||||||||||||||
| other income | 819,000 | 142,000 | 504,000 | 195,000 | 214,000 | 101,000 | 344,000 | 21,000 | 83,000 | 92,000 | 425,000 | 721,000 | 8,259,000 | -6,687,000 | 21,202,000 | 2,600,000 | -2,966,000 | 975,000 | 1,070,000 | 674,000 | 758,000 | 681,000 | 525,000 | 553,000 | 370,000 | 270,000 | 130,000 | 1,000 | -86,000 | -3,000 | 1,000 | 1,000 | 409 | 467 | -553,612 | ||||||||||||
| revenue from collaborative and other agreements | 7,093,000 | 8,956,000 | 11,986,000 | 27,168,000 | 15,184,000 | 51,746,000 | 17,415,000 | 15,636,000 | 12,967,000 | 24,556,000 | 17,984,000 | 9,987,000 | 10,917,500 | 20,617,000 | 18,552,000 | ||||||||||||||||||||||||||||||||
| product revenue | 3,580,000 | 4,668,000 | 3,591,000 | 3,203,000 | 887,000 | ||||||||||||||||||||||||||||||||||||||||||
| revenue from government agreements | 428,000 | 523,000 | 85,000 | 386,000 | 810,000 | 945,000 | 838,000 | 4,621,000 | 715,000 | 636,000 | 757,000 | 606,000 | 165,000 | 820,000 | 181,000 | 282,000 | 194,000 | 278,000 | 587,000 | 585,000 | 777,000 | 953,000 | |||||||||||||||||||||||||
| general and administrative | 12,561,000 | 9,732,000 | 10,216,000 | 10,233,000 | 11,890,000 | 11,833,000 | 12,122,000 | 10,219,000 | 10,547,000 | 9,584,000 | 11,134,000 | 9,235,000 | 8,404,000 | 8,403,000 | 8,384,000 | 7,462,000 | 7,239,000 | 6,133,000 | 6,715,000 | 6,021,000 | 5,346,000 | 4,683,000 | 4,845,000 | 3,678,000 | 4,145,000 | 3,258,587 | 3,763,785 | 1,986,555 | |||||||||||||||||||
| revenue from collaborative agreements | 9,497,000 | 4,501,000 | 152,081,000 | 1,076,000 | 1,081,000 | 1,278,000 | 1,893,000 | ||||||||||||||||||||||||||||||||||||||||
| basic net income per common share | -1,140 | 1,170 | -880 | 67.5 | -460 | -710 | 1,530 | -177.5 | -140 | -0.04 | 0.14 | ||||||||||||||||||||||||||||||||||||
| diluted net income per common share | -1,140 | 1,120 | -880 | 62.5 | -460 | -710 | 1,420 | -177.5 | -140 | -0.04 | 0.01 | ||||||||||||||||||||||||||||||||||||
| basic weighted-average common shares outstanding | 35,784,804,000 | 34,616,197,000 | 34,503,845,000 | 33,339,163,000 | 30,059,329,000 | 29,415,768,000 | 27,751,437,000 | ||||||||||||||||||||||||||||||||||||||||
| diluted weighted-average common shares outstanding | 35,784,804,000 | 36,017,411,000 | 34,503,845,000 | 33,339,163,000 | 30,059,329,000 | 31,684,174,000 | 27,751,437,000 | ||||||||||||||||||||||||||||||||||||||||
| revenue from collaborative research | 78,497,000 | 22,861,000 | 14,681,000 | 5,598,000 | 71,165,000 | 5,378,000 | 18,283,000 | 9,202,000 | 14,400,679 | 14,737,129 | 20,111,173 | ||||||||||||||||||||||||||||||||||||
| grant revenue | 2,176,000 | 308,000 | 1,118,000 | 114,000 | 98,000 | 99,000 | 18,000 | 317,918 | 169,307 | 120,895 | |||||||||||||||||||||||||||||||||||||
| net comprehensive income | 2,077,750 | -15,442,000 | -21,376,000 | 45,129,000 | -19,018,000 | -3,928,000 | -3,108,335 | -3,204,984 | 6,603,982 | ||||||||||||||||||||||||||||||||||||||
| net comprehensive loss | -12,259,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| weighted-average common shares outstanding, basic and diluted | 27,651,297,000 | 26,262,356 | |||||||||||||||||||||||||||||||||||||||||||||
| basic weighted-average number of common shares | 6,847,697 | 1,184,507 | |||||||||||||||||||||||||||||||||||||||||||||
| diluted weighted-average number of common shares | 6,847,697 | 21,242,978 |
We provide you with 20 years income statements for MacroGenics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MacroGenics stock. Explore the full financial landscape of MacroGenics stock with our expertly curated income statements.
The information provided in this report about MacroGenics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.